Breaking News

Halo Labs Completes $6M Growth Financing

New funding will be used for continued commercialization of Halo Labs' Aura platform.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Halo Labs, a life science instrumentation company raised $6 million in series C financing. The round was led by Agilent Technologies Inc. and includes participation from existing investors Research Corporation Technologies, Broad Oak Capital Partners, BioAdvance, and members of the Board of Directors and senior management.   This new funding will be used for continued commercialization of Halo Labs’ Aura platform, increasing manufacturing capacity and developing new products to meet the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters